Denali Capital Acquisition Corp. (DECA) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Denali Capital Acquisitio... (DECA)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

11.97

0.13 (1.10%)

At close: Jan 14, 2025, 9:56 AM

12.15

1.50%

Pre-market Jan 14, 2025, 09:57 AM EST

undefined% (undefined)

Bid	4.86
Market Cap	39.79M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.17
PE Ratio (ttm)	70.41
Forward PE	n/a
Analyst	n/a

Ask	12.49
Volume	545
Avg. Volume (20D)	2,765
Open	12.00
Previous Close	11.84
Day's Range	11.97 - 12.00
52-Week Range	4.05 - 12.00
Beta	undefined

About DECA

Denali Capital Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. It intends to complete a business combination with companies primarily operating in the technology, consumer, and hospitality sectors. The company was incorporated in 2022 and is based in New York, New York....

[Show more]

Industry Shell Companies

Sector Financial Services

IPO Date Jun 7, 2022

Employees 1

Stock Exchange NASDAQ

Ticker Symbol DECA

Why Price Moved

6 months ago · Source

+46.97%

Denali Capital Acquisition shares are trading high... Unlock content with Pro Subscription

News

4 months ago · reuters.com

Semnur Pharmaceuticals to go public via SPAC merger with Denali Capital in $2.5 bln deal

Semnur Pharmaceuticals, a wholly owned subsidiary of Scilex Holding Company , will go public via a merger with special purpose acquisition company Denali Capital Acquisition Corp in a $2.5 billion dea...

6 months ago · reuters.com

Semnur Pharmaceuticals to go public in SPAC deal of up to $2 billion with Denali Capital

Drug developer Semnur Pharmaceuticals said on Tuesday it has signed a letter of intent to go public through a merger with special purpose acquisition company Denali Capital Acquisition Corp in a pre-t...